En muchos casos pueden estar lesionadas sin poder hacer ejercicio, con perfil proinflamatorio, sueo deficiente, hinchazn permanente, niebla mental, olvidos frecuentes y, a menudo, prediabetes incipiente no diagnosticada
Only Wegovy is FDA-approved for weight loss and management
Orforglipron Phase 3 Results Show Promise for New GLP-1 Weight-Loss Pill (Updated 3/6/2026) A new oral weight-loss drug could soon join the rapidly evolving GLP-1 treatment landscape
Will GLP-1s affect cosmetic surgery plans
The global prevalence of this disease in humans has been estimated at 415 million adults in 2017 and is predicted to rise to 629 million by 2045 2
We understand that weight loss is a personal journey, which is why we are dedicated to providing you with the utmost care and support in not only your reproductive health, but also your overall health journey